-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
A Project of Shijiazhuang Sihua Pharmaceutical Wins the Third Prize in the Shijiazhuang High-Tech Achievement Implementation Award
Category:
发布时间：2023-05-11
【概要描述】
To accelerate the commercialization and implementation of high-tech achievements and promote the rapid development of our city’s high-tech industry, in accordance with the “Reward Measures for the Implementation of High-Tech Achievements in Shijiazhuang,” the Municipal People’s Government has decided to award units that have made outstanding contributions to the construction of high-tech industrialization projects and the commercialization of high-tech achievements in 2022. The “Industrialization of Basic Solution for Hemofiltration and Hemodiafiltration” project of Shijiazhuang Sihua Pharmaceutical Co., Ltd. was awarded the Third Prize in the Shijiazhuang High-Tech Achievement Implementation Award.
To accelerate the commercialization and implementation of high-tech achievements and promote the rapid development of our city’s high-tech industry, in accordance with the “Reward Measures for the Implementation of High-Tech Achievements in Shijiazhuang,” the Municipal Government has decided to award units that have made outstanding contributions to the construction of high-tech industrialization projects and the commercialization of high-tech achievements in 2022. The “Industrialization of Basic Solution for Hemofiltration and Hemodiafiltration” project of Shijiazhuang Sihua Pharmaceutical Co., Ltd. was awarded the Third Prize in the Shijiazhuang High-Tech Achievement Implementation Award.
The “Industrialization of Hemofiltration Replacement Basic Solution” project was developed based on the key technologies underlying the company’s receipt of the First Prize of the Hebei Provincial Science and Technology Progress Award for the project “Establishment and Application of a Quality Control System for Large Volume Parenteral Solutions in Flexible Packaging,” and incorporates three proprietary key technology patents. As one of only three domestic enterprises approved to manufacture hemofiltration replacement basic solutions, Shijiazhuang Sihua Pharmaceutical has conducted independent innovation and R&D on this product, completing process validation, quality standard development, and stability testing. By rigorously controlling critical process steps and parameters, the product quality meets the drug registration standards set by the National Medical Products Administration.
According to available information, the base solution used in hemofiltration and hemodiafiltration does not contain potassium ions or lactate, making it more suitable as a replacement fluid and effectively reducing the burden on the liver.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091